CD36 is a class B scavenger receptor recognizing a variety of ligands including long-chain fatty acids and modified LDL. We investigated whether genetic variability at this locus is a determinant of free fatty acids (FFA) plasma levels and risk of coronary artery disease in Caucasians. Typing of 21 polymorphic markers evenly spanning the CD36 gene revealed two linkage disequilibrium blocks that could be tagged by five polymorphisms (-33137A>G, -31118G>A, 25444G>A, 27645del>ins, and 30294G>C). In 585 non-diabetic individuals of Caucasian origin, the 30294G>C polymorphism was significantly associated with FFA levels (p=0.02) -an effect that was especially visible among men (p=0.009). A similar association was observed in this gender at -33137 (p=0.008) and -31118 (p=0.028).
INTRODUCTION
CD36 -also known as platelet glycoprotein IV or IIIb -is an 88 KDa membrane protein expressed on the surface of a wide variety of cell types including adipocytes, skeletal muscle cells, platelets, endothelial cells, and monocytes/macrophages (1) . Initially identified for its binding to collagen and thrombospondin (TSP-1) in platelets, CD36 is a class B scavenger receptor recognizing a variety of ligands including long-chain fatty acids, modified LDL, anionic phospholipids, Plasmodium Falciparum infected erythrocytes, and apoptotic cells (1) (2) (3) (4) .
Several recent findings suggest a role for CD36 as an important regulator of the metabolic pathways involved in insulin-resistance. CD36 facilitates the membrane transport of long-chain fatty acids (FA) into muscle and adipose tissues (5) . Increased FA availability can induce insulin resistance if the capacity of adipose tissue to store triglycerides and/or that of muscle to oxidize FA is exceeded (6).
As a result, alterations in CD36 level may be involved in the development of diet-induced insulinresistance as suggested by findings in rodents (7). Homozygous disruption of the CD36 locus in mice leads to hepatic insulin-resistance with high plasma free fatty acids and triglycerides (8,9). Transgenic rescue of CD36 in the spontaneously hypertensive rat (SHR) strain, in which the gene is severely mutated, ameliorates the metabolic syndrome typical of this animal model (10,11). Furthermore, CD36 is regulated by the peroxisome proliferator activated receptor gamma (PPARγ) and is a gene target of thiazolidinediones (TZDs), which are agonists of this nuclear receptor (12). Up-regulation of adipocyte or muscle CD36 by TZDs appears to mediate some of the insulin sensitizing effects of these drugs (13).
Atherosclerosis is a frequent and deadly complication of insulin resistance and diabetes (14).
Vascular dysfunction and atherosclerosis parallel the progression of the disease and may be accelerated by the dyslipidemia as well as the hyperglycemia that are prevalent in poorly controlled diabetes. In the arterial wall, CD36 contributes to the scavenging of oxidized LDL -one of the major triggers of atherosclerotic lesions (15, 16) . Thus, genetic variability in the expression or activity of this molecule may have an independent impact on the risk of coronary artery disease, in addition to that due to its effects on FFA levels and insulin-sensitivity.
at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from CD36 deficiency, mostly due to a Pro90Ser mutation, has been reported in Japanese and African subjects with a frequency of 2-4% (17, 18) . This condition has been associated to the metabolic syndrome in Japanese, with CD36 deficient individuals having impaired glucose disposal in response to insulin and increased levels of FFA, triglycerides, fasting blood glucose, and blood pressure (19) . Other studies have confirmed the association with higher plasma FFA, but not with other insulin-resistance traits (20) (21) . No data are available for Caucasians, owing to the rarity of the Pro90Ser mutation in this racial group (<0.3%).
Whether more common CD36 variants are also associated with specific metabolic phenotypes has not been fully investigated. Here we show in two different subpopulations that a common CD36 haplotype is associated among Caucasians with increased plasma FFA and triglycerides and is a determinant of increased cardiovascular risk in type 2 diabetes.
RESULTS
To determine the haplotype structure of the CD36 locus in Caucasians, 19 common SNPs (minor allele frequency ≥ 0.05) and two insertion/deletion polymorphisms were typed in 72 unrelated individuals from the general population. Eight of these markers were representative of the major linkage disequilibrium bins identified in the region between intron 3 and exon 14 by a resequencing project (http://pga.gs.washington.edu/data/cd36/). The other eleven were selected from the dbSNP database to cover the two alternative promoters (22) , the 5' non-coding exons, and the 3' UTR in exon 15. The 21 polymorphisms spanned a total of 63 Kb, resulting in a 3.0 Kb average spacing (Table 1 ). Significant linkage disequilibrium (LD) was observed across the entire locus ( Figure 1A ). However, two blocks of preferential LD appeared to be present, one extending from position -33137 to 15554, the other covering the remaining 15 kb ( Figure 1A ). This pattern was confirmed by haplotype analysis and the blockpartitioning algorithm implemented in the HapBlock software (23) . If the two blocks were considered separately, common (≥ 5%) haplotypes accounted for 80% of the haplotypes in the first block and 80% of those in the second block ( Figure 1B ). By contrast, if the entire locus was considered as a single block, common haplotypes accounted for only 69% of the chromosomes. Based on these findings, five haplotype tagging polymorphisms were selected, two from the first block (-33137A>G and -31118G>A), three from the second (25444G>A, 27645del, and 30294G>C) ( Figure 1B) .
The association between fasting FFA levels and the five haplotype tagging polymorphisms was investigated in 585 non-diabetic Caucasian individuals from Italy (231 men and 354 women), who had been characterized with respect to %IBW, waist circumference, blood pressure, fasting glucose and insulin, and lipid profile. As previously reported in the literature (24, 25) Table 2 . A significant difference in FFA levels across genotypes was observed at position 30294 (p=0.02) and a similar tendency was observed at position -33137 (p=0.069). When data were stratified by gender, the association between these two SNPs and FFA levels was much more evident in men (p=0.008 at -33137 and p=0.009 at 30294) than in women (NS, at both locations) ( Table 3 ). An association with FFA levels was also detected in men for SNP -31118 (p=0.028). At all three locations, men carrying the major allele had higher FFA levels than men homozygous for the minor allele, with a pattern consistent with an additive model being evident at -33137 and -31118 (p for linear trend =0.002 and 0.006, respectively). A similar pattern of association was observed at position -33137 for serum triglycerides (p=0.06, p for linear trend=0.027). No other metabolic traits or anthropometric measures were significantly associated with the five polymorphisms in either men or women (data not shown).
When the five polymorphisms were considered together, the AGGIG haplotype was associated in men with high levels of FFA (p=0.001), whereas the GAGIC haplotype was associated with low levels (p=0.023) (Figure 2A ). The AGGIG haplotype was more strongly associated with high FFA then any other haplotype carrying alleles associated with high FFA at individual loci ( Figure 2A ). The effect of this haplotype was similar in homozygosis or heterozygosis (p=0.45), with AGGIG carriers having 31% higher FFA levels than non-carriers (p=0.0002) ( Figure 2B ). A similar pattern was observed for triglycerides (20% increase in AGGIG carriers, p=0.025), but not for fasting insulin or other metabolic traits. No association between CD36 haplotypes and FFA or triglycerides levels was observed in women.
To determine whether the CD36 AGGIG haplotype was also associated with coronary artery disease (CAD), we typed two populations of Caucasian individuals with type 2 diabetes, one from Boston (n=197), the other from Italy (n=321). Each population included a group of cases with clinically significant CAD and a group of controls with negative cardiovascular history and a normal exercise treadmill test or angiography ( Table 4 ). The overall prevalence of AGGIG carriers was similar in the two populations and not significantly different from that in non-diabetic individuals (0.538 in type 2 diabetic subjects from Boston, 0.551 in type 2 diabetic subjects from Italy, and 0.578 in non-diabetic subjects).
Among the type 2 diabetic individuals from Boston, AGGIG carriers were significantly more frequent in CAD-positive cases than CAD-negative controls (OR=2.3, 95% CI 1.2-4.2, p=0.01 after adjusting for age, gender, and smoking) ( Table 5 ). An association between AGGIG haplotype and CAD was also present in the Italian study, although the effect was smaller and did not reach statistical significance with this sample size (OR=1.4, 95% CI=0.9-2.3, p=0.14). The odds ratios were not significantly different between the two populations (p=0.34), and when the two studies were considered together, the common estimate of the CAD risk associated with the AGGIG haplotype was 1.6 (95% CI 1.1-2.3, p=0.015) (table 5). In contrast with the findings for FFA, the increase in CAD risk associated with the AGGIG haplotype was similar in men and women (p=0.32 for interaction with gender). Results were similar when body weight and the prevalence of hypertension, which were different in cases and controls, were included in the logistic regression model (data not shown). The relation to serum lipid traits could not be evaluated because of the high prevalence of antilipidemic treatment in these individuals.
To identify common polymorphisms in functional regions that may be in linkage disequilibrium with the 'AGGIG' haplotype, we resequenced all exons together with 1.5 Kb of each promoter in 18
Caucasian individuals from the general population. One common sequence variants (-22674T>C) was detected that was not present in SNP databases. It was placed in the upstream promoter, 14 bases 5' of the at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from transcription start site, in the core of a binding element for the transcriptional repressor GFI1B. This SNP was in complete linkage disequilibrium with the -33137A>G htSNP. No common variants affecting the coding sequence were identified. We also analyzed the relationship between the five haplotype tagging polymorphisms and an intron 3 microsatellite (in3TGn) that was previously found to be associated with the expression of an alternative spliced, inactive transcript and increased susceptibility to cerebral malaria in Thai (26). Two major alleles were found at this locus in our Caucasian population, corresponding to 12 and 13 TG repeats, with frequencies of 0.427 and 0.443, respectively. The 13 repeat allele (the one associated with the expression of the inactive transcript in Thai) corresponded almost exactly to the A allele at position -33137, whereas the 12 repeat allele was associated with the G allele.
DISCUSSION
Previous studies, mostly from Japan, have reported an association between rare CD36 variants and high blood FFA and triglycerides (19) (20) (21) . Impaired insulin-mediated glucose disposal has been also documented, although results have not been uniform (19) (20) (21) . The aim of our study was to investigate whether more common polymorphisms at this locus could also affect lipid and glucose metabolism and influence cardiovascular risk. In a population of non-diabetic individuals of Caucasian ancestry, we found that one of the few common haplotypes occurring at this locus ('AGGIG') is associated with increased fasting levels of FFA and triglycerides. These findings are unlikely to be due to chance. First, the p value for the association with FFA is highly significant. Second, the same haplotype associated with FFA was significantly associated with a related phenotype (CAD) in an independent study, and a similar tendency was observed in yet another population. Nonetheless, the results of association studies must always be interpreted with caution (27,28), especially when multiple comparisons are performed, and replication in other settings is needed before a link between CD36 variability, FFA metabolism, and cardiovascular disease is firmly established.
The metabolic phenotype associated with the 'AGGIG' haplotype -higher FFA and triglycerides in the presence of normal insulin and glucose levels -duplicates, although on a smaller scale, the alterations displayed by the CD36 knockout mice (7-9). Thus, we postulate that the 'AGGIG' haplotype is associated with some degree of CD36 deficiency in the skeletal muscle and other tissues where the expression of CD36 is normally high. The resulting decrease in FFA clearance would raise the levels of plasma FFA, redirecting them to the liver where their uptake is independent of CD36 leading to increased production of triglycerides.
While the association between CD36 variants and FFA could be detected in the overall population, this genetic effect appears to be much stronger in men than women. The reasons for such sexual dimorphism are unclear, but may be related to the profound differences in FFA metabolism between genders, reflecting in part differences in the hormonal environment and body fat distribution.
Similar to the results of other studies (24, 25) , women from our population had significantly higher fasting FFA concentrations than men. Furthermore, the correlation between FFA levels and body weight or waist circumference was much weaker in this gender than in men (r=0.14 vs r=0.28 for %IBW, and r=0.12 vs r=0.23 for waist circumference). Thus, FFA metabolism appears to be under different regulatory mechanisms in men and women. If CD36 plays a more central role in men, its deficiency may have a bigger impact in this gender.
Increased FFA levels are toxic for endothelial cells and have been linked to increased cardiovascular risk in epidemiological studies (29-31). Thus, it is conceivable that the 'AGGIG' haplotype association with CAD is mediated by its association with increased FFA levels. However, the fact that the haplotype association with CAD was not restricted to men, as was the case for FFA, suggests that additional factors might be involved. CD36 also functions as a scavenger receptor for oxidized LDL and advanced glycation end products (AGEs), which are major triggers of inflammation and atherosclerosis in diabetic subjects (15, 16, 32, 33) . Thus, a reduced clearance of these metabolites could also contribute to the 'AGGIG' haplotype effect on CAD risk.
The number and identities of the causal variants responsible for these findings are unknown at this time. There are at least two candidate variants in the first linkage disequilibrium block. One (-22674T>C), which was identified in this study, is located in the CD36 upstream promoter. Allele T, which is in complete linkage disequilibrium with the FFA-associated allele A at -33137, determines the presence of a binding site for the transcriptional repressor GFI1B (34) , whereas allele C determines its absence. The other candidate variant is a TG microsatellite in intron 3. One of the alleles (13 repeats) has been reported to determine the expression of an alternative spliced, inactive transcript lacking exons 4 and 5 (26). This allele, which is associated with decreased P. falciparum clearance and increased malaria severity in Thai (26), is in complete linkage disequilibrium with the FFA-associated 33137A allele. In the second block, two of the polymorphisms defining the 'AGGIG' haplotype are placed in the 3' UTR where they could determine decreased mRNA stability.
Finally, some limitations of our study should be considered. One concerns the characterization of the haplotype structure at the CD36 locus. Data from the literature suggest that a 3.0 Kb SNP spacing should be narrow enough to identify all common (≥ 5%) haplotypes if extensive linkage disequilibrium is present as it is the case for CD36 (35) . Furthermore, for a large part of the gene we used polymorphisms representative of major linkage disequilibrium bins identified by a resequencing project (36) . However, we cannot exclude the possibility that other common haplotypes might be identified by further narrowing the SNP spacing. Thus, our study, though comprehensive, might have missed some genetic effects.
Another limitation is that we only considered basic metabolic traits such as fasting levels of metabolic substrates and insulin. Two caveats also apply to the results of the association study with CAD. One is that controls may have included individuals with significant CAD as a result of the occurrence of silent ischemia in diabetes and the less than perfect negative predictive value of the ETT (37). Because of this possible misclassification, the risk of CAD associated with the 'AGGIG' haplotype may have been underestimated. The other caveat is that the association with CAD was detected in diabetes -a condition characterized by increased FFA levels, increased production of oxidized LDL and AGE-modified proteins, and accelerated atherogenesis. Whether a similar effect is also present among normoglycemic individuals remains to be determined.
MATERIALS AND METHODS

Subjects
Non-diabetic individuals. The association between CD36 variants and metabolic traits was evaluated in 585 Caucasian residents of the Gargano area (East Coast of Italy). Subjects were recruited among the employees of the hospital 'Casa Sollievo della Sofferenza' (San Giovanni Rotondo, Italy), who had fasting plasma glucose < 7 mmol/l at screening and were not taking any medications. The study protocol and informed consent procedures were approved by the local research ethic committee. All study subjects were examined between 8:00 and 9:00 AM after an overnight fast. Height and weight were used to calculate body mass index (BMI) and percent ideal body weight (% IBW, calculated by multiplying BMI by 4.39 for males and 4.76 for females). Waist circumference (the widest value between the lower rib margin and the iliac crest) was measured with a plastic measuring tape by the same investigator in all subjects while standing. Systolic and diastolic (disappearance of Korotkoff sound, phase V) blood pressures were measured in the sitting position with an appropriately sized cuff after a 5 minutes rest.
Plasma glucose (mmol/l), serum insulin (pmol/l) and lipid profile (total serum cholesterol, HDL cholesterol, serum triglycerides) were measured using commercially available enzymatic kits as previously described (38) . Plasma free fatty acids were determined by a microenzymatic assay as described by Shimuzu et al. (39) and implemented in the NEFA C Test Kit (Wako Chemicals USA, Richmond, VA). This measurement is based on the esterification of FFA to acyl-CoA by means of acylCoA synthase followed by acyl-CoA oxidation with acyl-CoA oxidase and measurement of the resulting hydrogen peroxide with a colorimetric method. The intra-and inter-assay coefficients of variation were 2.2% and 2.8%, respectively.
Case-controls studies. Two populations of individuals with type 2 diabetes (defined according to the WHO criteria) were studied, one from Boston (n=197), the other from San Giovanni Rotondo, Italy (n=321). The study protocol and informed consent procedures were approved by the local research ethic committees. Each population included a group of CAD-positive cases and a group of CAD-negative controls. In the Boston study, the CAD-positive cases -defined as subjects who had a stenosis greater than 50% in at least one major coronary artery or their main branches -were recruited among type 2 diabetic patients who underwent cardiac catheterization at the Beth Israel Deaconess Medical Center Clinical features of cases and controls from the two studies are shown in Table 4 .
SNP Genotyping.
Fifty-two polymorphisms spanning the entire CD36 locus were selected from the dbSNP database. Of these, 21 turned out to have a minor allele frequency ≥0.05 in Caucasians and were amenable to reliable genotyping using the methods available in our laboratory (see below). Eight of these polymorphisms were representative of the major linkage disequilibrium bins identified in the region between intron 3 and exon 14 by a resequencing project (http://pga.gs.washington.edu/data/cd36/). In the initial linkage disequilibrium study, 72 subjects from the general population subjects were typed at these 21 polymorphic loci by means of PCR followed by dot blotting and allelic specific hybridization or gel electrophoresis (for the insertion/deletion at 27645). The five haplotype-tagging polymorphisms were then typed in the study groups by single base extension/fluorescence polarization (AycloPrime-FP SNP Detection System) using a Wallac VICTOR 2 Multilabel Plate Reader (Perkin-Elmer) or agarose gel electrophoresis (27645Ins/Del). Genotyping quality was tested by including six blinded duplicate samples in each 96-well assay. The average agreement rate of duplicate samples was >97%. Sequences of the primers and probes used for typing are available from the authors. denotes any haplotype other than AGGIG and GAGIC. Data refer to 167 men for whom genotypes were available for all tag polymorphisms and the assigned diplotypes had ≥ 75% probability; p=0.0002 for AGGIG carriers versus non-carriers. -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2506A>G  3778A>T  11554C>T  15341G>A  18672del  21663G>C  25443G>A  27664del  30214G>A  30293G>C Ha p lo typ e F re q u e n cy -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2507A>G  3779A>T  11555C>T  15342G>A  18673del  21664G>C  25444G>A  27645del  30215G>A  30294G>C 0.00
1.00 A   -33137A>G  -31118G>A  -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2507A>G  3779A>T  11555C>T  15342G>A  18673del  21664G>C  25444G>A  27665del  30215G>A -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2506A>G  3778A>T  11554C>T  15341G>A  18672del  21663G>C  25443G>A  27664del  30214G>A  30293G>C Ha p lo typ e F re q u e n cy -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2507A>G  3779A>T  11555C>T  15342G>A  18673del  21664G>C  25444G>A  27645del  30215G>A  30294G>C 0.00
1.00 A   -33137A>G  -31118G>A  -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2507A>G  3779A>T  11555C>T  15342G>A  18673del  21664G>C  25444G>A  27665del  30215G>A  30294G>C  -33137A>G  -31118G>A  -28927A>G  -22602A>T  -22146T>C  -10606T>C  -10432G>T  -8153G>T  -4949G>A  -3489T>C  -602A>C  2507A>G  3779A>T  11555C>T  15342G>A  18673del  21664G>C  25444G>A  27665del  30215G>A  30294G>C -33137A>G Figure 2 Ha 
